Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Blood Adv (2021) 5 (19): 3862–3872.

https://doi.org/10.1182/bloodadvances.2021004778

Published: 2021

Includes: Supplemental data

Journal Articles

Management of acquired hemophilia A: results from the Spanish registry

María-Eva Mingot-Castellano, Josep Pardos-Gea, Saturnino Haya, José-María Bastida-Bermejo, Dolors Tàssies, Ana Marco-Rico, Ramiro Núñez, Faustino García-Candel, María-Carmen Fernández-Sanchez de Mora, Inmaculada Soto, María-Teresa Álvarez-Román, Susana Asenjo, Marina Carrasco, Rafael Lluch-García, José-Manuel Martín-Antorán, Agustín Rodríguez-Alén, Elena Roselló, Laura Torres-Miñana, Shally Marcellini-Antonio, Ana Moretó-Quinana, José-Antonio Rodríguez-García, Reyes Aguinaco-Culebras, Nieves Alonso-Escobar, Carlos Cervero-Santiago, Núria Fernández-Mosteirín, María-Paz Martínez-Badás, Montserrat Pérez-Sánchez, Rocío Pérez-Montes, Ramón Rodríguez-González, Marisol Uribe-Barrientos, Isabel Socorro Caparrós-Miranda, Miriam Iglesias-Fernández, Ángela Baena, Manuel Rodríguez-López, Ana Sebrango-Sandia, Irene Vázquez-Fernández, Pascual Marco, on behalf of the Acquired Haemophilia Spanish Registry of the Spanish Society of ThrombosisHaemostasis (SETH)

Blood Adv (2021) 5 (19): 3821–3829.

https://doi.org/10.1182/bloodadvances.2021004626

Published: 2021

Includes: Supplemental data

Journal Articles

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher D’Angelo, Umar Farooq, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Yazdy, Emma Rabinovich, Frank A. Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A. Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M. Haverkos, Victor M. Orellana-Noia, Vaishalee P. Kenkre, Adam Zayac, Seth M. Maliske, Narendranath Epperla, Paolo Caimi, Scott E. Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A. Feldman, Daniel Rector, Stephen D. Smith, Andrzej Stadnik, Craig A. Portell, Yong Lin, Seema Naik, Silvia Montoto, Izidore S. Lossos, Kate Cwynarski

Blood Adv (2021) 5 (14): 2852–2862.

https://doi.org/10.1182/bloodadvances.2021004458

Published: 2021

Includes: Supplemental data

Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura

Blood Adv (2021) 5 (12): 2650–2659.

https://doi.org/10.1182/bloodadvances.2021004192

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review

Edward J. Bataillard, Chan Yoon Cheah, Matthew J. Maurer, Arushi Khurana, Toby A. Eyre, Tarec Christoffer El-Galaly

Blood Adv (2021) 5 (9): 2426–2437.

https://doi.org/10.1182/bloodadvances.2021004665

Published: 2021

Includes: Supplemental data

Journal Articles

Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis

Hyehyun Jeong, Hyungwoo Cho, Hyeyeong Kim, Heejung Chae, Jung-Bok Lee, Kyoungmin Lee, Shin Kim, Sang-wook Lee, Jin-Sook Ryu, Kyung Won Kim, Eun Jin Chae, Jooryung Huh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh

Blood Adv (2021) 5 (8): 2142–2152.

https://doi.org/10.1182/bloodadvances.2020003947

Published: 2021

Includes: Supplemental data

Journal Articles

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Alden A. Moccia, Kimberly Schaff, Ciara Freeman, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn

Blood Adv (2021) 5 (5): 1483–1489.

https://doi.org/10.1182/bloodadvances.2020002982

Published: 2021

Includes: Supplemental data

Journal Articles

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Amy E. DeZern, Clio Franklin, Hua-Ling Tsai, Phil Hollingsworth Imus, Kenneth R. Cooke, Ravi Varadhan, Richard J. Jones

Blood Adv (2021) 5 (5): 1360–1368.

https://doi.org/10.1182/bloodadvances.2020003922

Published: 2021

Includes: Supplemental data

Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli

Blood Adv (2021) 5 (5): 1333–1339.

https://doi.org/10.1182/bloodadvances.2020003707

Published: 2021

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Daisuke Kaji, Yasunori Ota, Yasuharu Sato, Koji Nagafuji, Yasunori Ueda, Masataka Okamoto, Yasushi Terasaki, Naoko Tsuyama, Kosei Matsue, Tomohiro Kinoshita, Go Yamamoto, Shuichi Taniguchi, Shigeru Chiba, Koichi Ohshima, Koji Izutsu

Blood Adv (2020) 4 (18): 4442–4450.

https://doi.org/10.1182/bloodadvances.2020002293

Published: 2020

Includes: Supplemental data

Journal Articles

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Marco Basset, Paolo Milani, Mario Nuvolone, Francesca Benigna, Lara Rodigari, Andrea Foli, Giampaolo Merlini, Giovanni Palladini

Blood Adv (2020) 4 (17): 4175–4179.

https://doi.org/10.1182/bloodadvances.2020002219

Published: 2020

Includes: Supplemental data

Journal Articles

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany

Blood Adv (2020) 4 (16): 4007–4019.

https://doi.org/10.1182/bloodadvances.2020002178

Published: 2020

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

Scott R. Solomon, Melhem Solh, Xu Zhang, Stacey Brown, Katelin C. Jackson, H. Kent Holland, Lawrence E. Morris, Asad Bashey

Blood Adv (2020) 4 (15): 3669–3676.

https://doi.org/10.1182/bloodadvances.2020001958

Published: 2020

Includes: Supplemental data

Journal Articles

In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure

Mathieu Simonin, Anne Auperin, Yves Bertrand, Nathalie Aladjidi, André Baruchel, Audrey Contet, Carole Coze, Virginie Gandemer, Stephanie Haouy, Thierry Leblanc, Guy Leverger, Jean Michon, Catherine Patte, Veronique Minard-Colin

Blood Adv (2020) 4 (15): 3621–3625.

https://doi.org/10.1182/bloodadvances.2019001398

Published: 2020

Journal Articles

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Diego Villa, Laurie H. Sehn, Kerry J. Savage, Cynthia L. Toze, Kevin Song, Wendie D. den Brok, Ciara L. Freeman, David W. Scott, Alina S. Gerrie

Blood Adv (2020) 4 (15): 3486–3494.

https://doi.org/10.1182/bloodadvances.2020002068

Published: 2020

Includes: Supplemental data

Journal Articles

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Blood Adv (2020) 4 (14): 3382–3390.

https://doi.org/10.1182/bloodadvances.2020001551

Published: 2020

Includes: Supplemental data

Journal Articles

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Seongseok Yun, Onyee Chan, Daniel Kerr, Nicole D. Vincelette, Afshan Idrees, Qianxing Mo, Kendra Sweet, Jeffrey E. Lancet, Mohamed A. Kharfan-Dabaja, Ling Zhang, Lubomir Sokol

Blood Adv (2020) 4 (14): 3435–3442.

https://doi.org/10.1182/bloodadvances.2020001875

Published: 2020

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Management of acquired hemophilia A: results from the Spanish registry

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review

Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Primary human herpesvirus 8–negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant

In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only